enior Associate - East Africa Pharmaceutical Manufacture and Supply, Nairobi

Senior Associate - East Africa Pharmaceutical Manufacture and Supply, Nairobi

More vacancies from: Organization Clinton Health Access Initiative (CHAI) Country Kenya City Nairobi, Kenya

Overview Founded in 2002 by President William J. Clinton, the Clinton Health Access Initiative (CHAI) is a global health organization committed to strengthening integrated health systems around the world and expanding access to care and treatment for HIV/AIDS, malaria and other illnesses. Based on the premise that business oriented strategy can facilitate solutions to global health challenges, CHAI acts as a catalyst to mobilize new resources and optimize the impact of these resources to save lives, via improved organization of commodity markets and more effective local management. By working in association with governments and other NGO partners, CHAI is focused on large-scale impact and, to date, CHAI has secured lower pricing agreements for treatment options in more than 70 countries. In addition, CHAI's teams are working side-by-side with over 30 governments to tackle many of the largest barriers to effective treatment and care. CHAI is undertaking a series of market shaping initiatives designed to strengthen the East African pharmaceutical industry's competitive position and market share of the health pharmaceutical market, while increasing access to international quality and affordable medicines. This role will involve engaging with senior private sector and government stakeholders across Burundi, Kenya, Rwanda, Tanzania, and Uganda. The ultimate goal is for at least two East African local manufacturers to produce international quality pharmaceuticals at a cost competitive price point, and for these products to be procured by international buyer(s) by year-end 2015. This test case will connect local manufacturers to international buyers, strengthen the long-term viability of industry, and provide a roadmap for other initiatives supporting local industry to drive broader transformation. The Senior Associate must be able to function independently and flexibly as well as build strong relationships with government officials and partners across the public and private sectors. CHAI places great value on relevant personal qualities: resourcefulness, entrepreneurialism, flexibility, integrity, independence, humility, and a positive work ethic. This is a challenging though rewarding position that directly impacts the quality and cost of pharmaceutical products in East Africa. Further, it will build local industry and technical capacity for continued advancement in the manufacturing sector. It is an opportunity to work on a unique market transformation, and collaborate closely with partner governments, private sector entities, and international agencies. Position Overview CHAI is seeking a Senior Associate to lead technical and strategic assistance to local pharmaceutical manufacturers and government partners. A major component of the role will entail supporting to local manufacturers as they work to identify and implement cost reduction opportunities in all aspects of the production process. It is expected the Senior Associate will independently manage this work stream. The Senior Associate will also be actively involved in the quality improvement component of the project, coordinating the provision of support to local manufacturers to reach international cGMP (such as WHO PQ). This will involve working with GMP experts to undertake cGMP GAP assessments, assisting local manufacturers cost interventions and developing the business case for high-impact interventions. The Senior Associate will support the implementation of cost/quality interventions ensuring projects run to time and budget. Throughout this project, on a needs basis, the Senior Associate will engage national, regional and international bodies (such as the EAC, and WHO) in relation to this work, and broader adaption of project principles. Responsibilities Support East African pharmaceutical manufacturers to identify and implement production optimisation opportunities. Work with C-Level counterparts to develop business case for board approval. Assist technical experts undertaking cGMP diagnostic assessments of local manufacturers. Accelerate the adoption and implementation of recommendations by local manufacturers. Support relevant public/private sector entities within the EAC in undertaking operations focused assessments to improve efficiency and reach performance targets. This may include procurement entities, regulatory authorities, MoH, and private sector entities. Manage the development and maintenance of market intelligence database on the pharmaceutical industry in Kenya, including associated quantitative models and forecasts. Support evolving team priorities within a non-hierarchical structure. Qualifications A Bachelors Degree in Process/Industrial Chemistry, Pharmacy, Biochemistry, or related field. At 3-5 years experience in a relevant industry with increasing levels of responsibility. Ability to work collaboratively and creatively with a wide range of stakeholders to influence change and achieve results. Ability to leverage data to create solution orientated analyses for C-Level stakeholders. Ability to handle multiple tasks simultaneously, set priorities and work with autonomy. Exceptional analytical, research and presentation skills of qualitative and quantitative data Excellent interpersonal skills, including the ability to communicate at all levels, and experience managing senior clients/sensitive relationships. Willingness to travel to focus countries and other locations with limited advance notice. Advantages: Preference will be given to candidates with demonstrated experience in the pharmaceutical industry and an MBA or equivalent post-graduate qualification. Content experience, particularly roles supporting production optimisation opportunities will be a distinct advantage. Candidates with pharma industry experience through private equity, management consulting, or similar, will also be given serious consideration, as will be those with Government/Regulatory authorities experience in the pharmaceutical industry.